NCI-H1703  Xenograft

 

 

Rincon Bio performs NCI-H1703 xenograft models to test efficacy of preclinical therapies.  Please see below for additional information or to request a quote. 

Lung

Organism: Homo sapiens, human  /  Cell Type: squamous cell  /  Tissue: lung  /  Disease: lung; squamous cell; non-small cell lung cancer

Notes

NCI-H1703 was derived from a stage 1 lung squamous cell carcinoma of a 54-year-old Caucasian male smoker.

in vivo

Used in xenografts to test the efficacy of novel cancer therapeutics.  Tumors develop after being injected into the flank of immunocompromised mice. 

Request Quote

Receive a quote within one business day for a NCI-H1703 Xenogrft

Rincon Bio Growth Curve

nci-h1703.png

Cell Line: NCI-H1703

Mouse Strain: Nude

Positive Control: None

Concentration: N/A

Matrigel: Yes

Dosing: N/A

Stratified: N/A

From implant to stratification: N/A

Cells Implanted per Animal: 4 million

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY at COMPETITIVE PRICES

 

When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices

SPEED TO INITIATION
 

Most efficacy studies can be initiated within two business days.

PERSONAL TOUCH

 

We love our clients!  We are flexible and easy to work with.  And we take a personal interest in our clients' studies.